ArticleFrontiers in pharmacology2022

A novel nomogram and prognostic factor for metastatic renal cell carcinoma survival in the era of immune checkpoint inhibitors (ICIs).

Mohammed Alradhi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.